MarketInOut Stock Screener Log In | Sign Up

Sernova Biotherapeutics Inc

TSX • Healthcare • Biotechnology • Quote as of 10/27/2026 15:06
Sernova Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization41.54 mln
Float337 mln
Earnings Date09/10/2026

EPS

0.01
Marginal

P / E

10.50
Fair value

Piotroski F-Score

3 / 9
Below average

Relative Strength

55 / 100
Slightly ahead

ROE

57.10
Exceptional

ROA

-1,119
Deeply negative

Business Description

Sernova Biotherapeutics is a Canadian medical company working to develop treatments that use living cells to restore natural body functions lost to disease. Its core technology, the Cell Pouch, is a small implantable device that creates a stable, blood-supplied environment where therapeutic cells can survive and function long-term, while remaining retrievable if needed. Based in Mississauga, the company was previously known as Sernova Corp before adopting its current name in early 2025.

Key Fundamentals

EPS0.01
P/E10.50
ROE57.10
ROIC-59.69
ROA-1,119
Interest Cover-6.37
EBITDA, mln-8.70
EV / EBITDA-5.58
EV / EBIT-5.53

Quote Details

Last 0.11
Change 0 (0%)
Open 0.11
Volume 29,778
Turnover 3,275.58
Average Volume 170,550

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.59

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.35% 10 / 100   
1 Month 22.22% 98 / 100   
2 Months 0% 45 / 100   
6 Months -35.29% 4 / 100   
1 Year -33.33% 8 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog